Beranda539871 • BOM
add
Thyrocare Technologies Ltd
Tutup sebelumnya
₹970,35
Rentang hari
₹945,60 - ₹975,90
Rentang tahun
₹545,05 - ₹1.002,00
Kapitalisasi pasar
50,65Â M INR
Volume Rata-Rata
6,71Â rb
Rasio P/E
61,01
Hasil dividen
1,88%
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,77Â M | 19,84% |
Biaya operasional | 616,60Â jt | 22,27% |
Laba bersih | 266,70Â jt | 31,12% |
Margin laba bersih | 15,04 | 9,46% |
Penghasilan per saham | 4,98 | — |
EBITDA | 474,35Â jt | 27,82% |
Tarif pajak efektif | 28,15% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,38Â M | 38,47% |
Total aset | 5,97Â M | 0,74% |
Total liabilitas | 1,08Â M | 3,20% |
Total ekuitas | 4,89 M | — |
Saham yang beredar | 53,45 jt | — |
Harga terhadap nilai buku | 10,62 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 16,35% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 266,70Â jt | 31,12% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Didirikan
1996
Kantor pusat
Situs
Karyawan
1.693
